Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable
PREDICT study
Approved small_molecule active
Quick answer
Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable for Cardiovascular device infections is a Approved program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Cardiovascular device infections
- Phase
- Approved
- Modality
- small_molecule
- Status
- active